Moreover, the inhibitor of NF-κB can effectively inhibit the progression of HCC, suggesting that inhibition of NF-κB signaling may be an effective method to treat HCC using small molecule inhibitor of NF-κB. But this needs more evidence. Here, NFKB1 is linked to hepatocellular carcinoma.